Aminopiperidine Amides for CXCR4 Modulation and Stem Cell Mobilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies lack effective modulators for CXCR4, a receptor involved in various inflammatory diseases and cancer, limiting treatment options for conditions such as rheumatoid arthritis, autoimmune diseases, and pulmonary fibrosis.
Innovation Solution
Development of aminopiperidine amides and their derivatives as CXCR4 modulators, which can be administered to treat or prevent inflammatory conditions, cancer, and enhance hematopoietic stem/progenitor cell mobilization by targeting the CXCR4 receptor.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If current therapies are used, then treatment options are limited, but effective modulators for CXCR4 are lacking
Solution Approach 1:
The patent applies parameter changes by systematically varying chemical parameters of the aminopiperidine amide structure (different R1, R2, R3 substituents) to optimize CXCR4 binding affinity and selectivity. This allows generation of multiple analogs with improved therapeutic properties while maintaining the core pharmacophore structure.
Solution Approach 2:
The patent employs local quality by introducing specific functional groups at particular positions on the piperidine ring (N-substituents, 4-substituents, and amide variations) to enhance specific interactions with CXCR4 receptor pockets. Each local modification is designed to improve binding at specific regions while maintaining overall molecular stability.
2Reliability
If aminopiperidine amides are developed as CXCR4 modulators, then therapeutic benefits are improved, but device complexity increases
Solution Approach 1:
The patent achieves universality by designing the aminopiperidine amide core structure to serve multiple therapeutic functions: CXCR4 antagonism for inflammatory diseases, potential anti-cancer activity, and stem cell mobilization. The versatile scaffold can address multiple disease mechanisms through a single molecular platform.
Solution Approach 2:
The patent applies composite materials by combining the piperidine ring system with various amide functionalities and aromatic substituents to create a composite molecular structure. This composite approach integrates different functional elements (basic nitrogen, amide bond, aromatic systems) to achieve optimal binding properties and pharmacokinetic characteristics.
Data Source
AI summary
This disclosure relates to aminopiperidine amides, derivatives, pharmaceutical compositions, and uses related to CXCR4 modulation. In certain embodiments, the aminopiperidine amides are compounds having formula I, salts, derivatives, and prodrugs thereof wherein, R1, R2, and R3 are further defined herein. In certain embodiments, this disclosure contemplates pharmaceutical compositions comprising compounds disclosed herein. In certain embodiments, this disclosure relates to methods of treating or preventing CXCR4 related diseases or conditions by administering an effective amount of a compound disclosed herein to a subject in need thereof.